2011
DOI: 10.1172/jci57734
|View full text |Cite
|
Sign up to set email alerts
|

Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease

Abstract: Pulmonary hypertension is a severe and progressive disease, a key feature of which is pulmonary vascular remodeling. Several growth factors, including EGF, PDGF, and TGF-β1, are involved in pulmonary vascular remodeling during pulmonary hypertension. However, increased knowledge of the downstream signaling cascades is needed if effective clinical interventions are to be developed. In this context, calpain provides an interesting candidate therapeutic target, since it is activated by EGF and PDGF and has been r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
101
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 95 publications
(116 citation statements)
references
References 79 publications
14
101
0
1
Order By: Relevance
“…Both bone morphogenetic proteins (BMPs) and TGF-β isoforms that mediate signaling are believed to be involved in PA remodeling in PAH (34). Consistent with previous reports (35,36), we observed that hypoxia suppressed the expression of the inhibitor of differentiation 1 (ID1) (Supplemental Figure 9A), a downstream target of the BMP receptor 2 pathway, and hypoxia induced the expression of PAI-1, a target of TGF-β1 signaling (Supplemental Figure 9B), in mPASMCs. Meanwhile, Ep3 deletion attenuated hypoxia-stimulated PAI-1 expression without significant influence on ID1 expression, indicating that the EP3 receptor may modulate TGF-β1 signaling in mPASMCs.…”
Section: Resultssupporting
confidence: 84%
“…Both bone morphogenetic proteins (BMPs) and TGF-β isoforms that mediate signaling are believed to be involved in PA remodeling in PAH (34). Consistent with previous reports (35,36), we observed that hypoxia suppressed the expression of the inhibitor of differentiation 1 (ID1) (Supplemental Figure 9A), a downstream target of the BMP receptor 2 pathway, and hypoxia induced the expression of PAI-1, a target of TGF-β1 signaling (Supplemental Figure 9B), in mPASMCs. Meanwhile, Ep3 deletion attenuated hypoxia-stimulated PAI-1 expression without significant influence on ID1 expression, indicating that the EP3 receptor may modulate TGF-β1 signaling in mPASMCs.…”
Section: Resultssupporting
confidence: 84%
“…For calpain inhibitor studies, calpain inhibitor III was injected once daily for 7 days intraperitoneally (30 mg/kg body weight) starting the same day as NTS injection. Control mice received an equal volume of PEG400/DMSO (65,66). Mice urine samples were obtained on days 0 and 7 and were evaluated for calpain activity following NTS injection.…”
Section: Methodsmentioning
confidence: 99%
“…Four epoxyeicosatrienoic acid (EET) regioisomers (5,8,11,(12)(13)(14) are the metabolites of AA by the cytochrome 450 (CYP) monooxygenase pathway (9,10). Similar to many eicosanoids, EETs have multiple biological functions, including the regulation of cardiovascular inflammation, the reduction of blood pressure, as well as anti-atherosclerotic functions in multiple model systems.…”
Section: Introductionmentioning
confidence: 99%
“…Sturrock et al (7) demonstrated that TGF-β1 is abundantly expressed in patients with pulmonary hypertension, and promotes pulmonary artery smooth muscle cell (PASMC) proliferation in low serum medium. The inhibition of TGF-β1 signaling has been demonstrated to attenuate pulmonary vascular remodeling and increase right ventricular pressure in animal models (8).…”
Section: Introductionmentioning
confidence: 99%